Thurston, Springer, Miller, Herd & Titak, Inc. Haemonetics Corp Transaction History
Thurston, Springer, Miller, Herd & Titak, Inc.
- $558 Million
- Q1 2025
A detailed history of Thurston, Springer, Miller, Herd & Titak, Inc. transactions in Haemonetics Corp stock. As of the latest transaction made, Thurston, Springer, Miller, Herd & Titak, Inc. holds 99 shares of HAE stock, worth $5,882. This represents 0.0% of its overall portfolio holdings.
Number of Shares
99
Previous 111
10.81%
Holding current value
$5,882
Previous $8,000
25.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding HAE
# of Institutions
344Shares Held
51.7MCall Options Held
600KPut Options Held
474K-
Black Rock Inc. New York, NY5.96MShares$354 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.18MShares$308 Million0.01% of portfolio
-
Neuberger Berman Group LLC New York, NY4.42MShares$263 Million0.29% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.24MShares$252 Million0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.55MShares$152 Million0.12% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $3.05B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...